|
We are building a portfolio of compounds that have first-in-class and best-in-class potential through our own discovery research and clinical development initiatives.
more >
|
 |
Information not available at this time
|
|
Exelixis presented 15 posters at the 20th Annual EORTC Symposium which was held October 21-October 24 in Geneva, Switzerland.
more >
Information not available at this time
|
|
Looking for a career at Exelixis? We are looking for people to join us as we turn our vision into reality.
more >
NASDAQ: EXEL
Information not available at this time
|
